{
    "2020-04-09": [
        [
            {
                "time": "",
                "original_text": "互联网医疗龙头获机构扎堆推荐，机构关注这些高景气行业龙头公司",
                "features": {
                    "keywords": [
                        "互联网医疗",
                        "龙头",
                        "机构推荐",
                        "高景气行业"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "互联网"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "一季报|华兰生物业绩差强人意 新冠疫苗在途股价早已扬鞭",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "一季报",
                        "新冠疫苗",
                        "股价上涨"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[华兰生物 | Q1业绩点评]疫情影響短期业绩，血制品与疫苗长期景气度将双升",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "Q1业绩",
                        "疫情",
                        "血制品",
                        "疫苗",
                        "长期景气度"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药板块延续强势 机构建议关注原料药板块",
                "features": {
                    "keywords": [
                        "医药板块",
                        "强势",
                        "原料药",
                        "机构建议"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "防御股价值进一步凸显",
                "features": {
                    "keywords": [
                        "防御股",
                        "价值凸显"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "防御性股票"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "招商证券：三大方面深度解析血制品行业(个股分析)",
                "features": {
                    "keywords": [
                        "招商证券",
                        "血制品行业",
                        "个股分析"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[山证医药]华兰生物（002007.SZ） ：血制品业务有所下滑，预计全年仍将维持稳定增长 盈利能力下降",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "血制品",
                        "盈利能力下降",
                        "稳定增长"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}